CEMI
CEMI Real Time Price USDRecent trades of CEMI by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Tom Malinowski House / D | Sale $1,001 - $15,000 | Mar. 19, 2020 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by CEMI's directors and management
Government lobbying spending instances
-
$10,000 Apr 16, 2022 Issue: Medical/Disease Research/Clinical Labs Manufacturing
-
$10,000 Jan 18, 2022 Issue: Medical/Disease Research/Clinical Labs Manufacturing
-
$10,000 Oct 16, 2021 Issue: Medical/Disease Research/Clinical Labs Manufacturing
-
$10,000 Jul 17, 2021 Issue: Manufacturing Medical/Disease Research/Clinical Labs
-
$10,000 Apr 20, 2021 Issue: Manufacturing Medical/Disease Research/Clinical Labs
-
$20,000 Oct 17, 2013 Issue: Health Issues
-
$10,000 Jul 18, 2013 Issue: Health Issues
-
$60,000 Feb 12, 2007 Issue: Health Issues
-
$40,000 Aug 11, 2006 Issue: Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of CEMI in WallStreetBets Daily Discussion
Recent insights relating to CEMI
Recent picks made for CEMI stock on CNBC
ETFs with the largest estimated holdings in CEMI
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CEMI Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.